The U.S. Food and Drug Administration (FDA) recently released its annual Strategic Policy Roadmap (PDF), outlining the Agency's key priorities for the upcoming year. The document highlights four strategic policy areas that will spur activity in 2018. These strategic objectives include reducing the burden of addiction crises that are threatening American families, leveraging innovation and competition to improve health care, broadening access and advancing public health goals, empowering consumers to make better and more informed decisions about their diets and health, expanding the opportunities to use nutrition to reduce morbidity and mortality and strengthening the FDA's scientific workforce and its tools for efficient risk management, among others.

In his announcement, FDA Commissioner Scott Gottlieb, MD, stated that several of these efforts are already in progress, and the others will move forward in the near future. He also noted that the selected goals are at the core of the FDA's mission to advance and protect public health while upholding its commitment to scientific standards.

Keywords: ACC Advocacy, Public Health, United States Food and Drug Administration, Nutritional Status, Diet, Morbidity, Delivery of Health Care, Risk Management

< Back to Listings